 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
1 News |  |
- || MASCT-I / HRYZ BIOTECH
New P1 trial: MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy. (clinicaltrials.gov) - May 26, 2023
P1, N=22, Completed, Sponsor: SYZ Cell Therapy Co..
- MASCT-I / HRYZ BIOTECH
New P1/2 trial, Metastases: MASCT-I Treatment for Advanced Solid Tumor (clinicaltrials.gov) - Aug 8, 2016
P1/2, N=46, Not yet recruiting, Sponsor: The First People's Hospital of Lianyungang